Coherent, Inc. (NASDAQ: COHR) reported Q1 EPS of $0.94, $0.08 better than the analyst estimate of $0.86. Revenue for the quarter came in at $203.7 million versus the consensus estimate of $200.78 million.

"We are pleased by the solid results in our second quarter including the acceleration in demand across our commercial markets. Our FPD business picked up with new system and higher service orders. The outlook in FPD is strong and we expect a number of new system orders over the next few quarters," stated John Ambroseo, Coherent's President and Chief Executive Officer. "Orders in other commercial areas were very encouraging. The via drilling market continues to improve and we received multiple volume orders for our J-Series Hornet™ laser and have more opportunities on the horizon. The bioinstrumentation and medical OEM market posted record orders. Instrumentation customers' confidence grew and they reverted to longer-term purchases, primarily for our OBIS™ portfolio. The medical OEM market was very robust for ophthalmic (cataract and disease management), home-based aesthetic, dental and medical consumables (disposable fibers)," Ambroseo added.

For earnings history and earnings-related data on Coherent, Inc. (COHR) click here.